276249-18-4 Usage
Uses
Used in Pharmaceutical Research:
6-CHLORO-3,5-DIOXO HEXANIC ACID, 1,1-DIMETHYL ETHYL ESTER is used as a research chemical for its ability to inhibit a specific enzyme, which is crucial in the study of biochemical processes and the development of new drugs targeting those enzymes.
Used in Chemical Synthesis:
In the chemical industry, 6-CHLORO-3,5-DIOXO HEXANIC ACID, 1,1-DIMETHYL ETHYL ESTER serves as a building block in the synthesis of other compounds, contributing to the creation of novel pharmaceuticals and chemical products.
Used in Environmental and Health Regulations:
Due to its potential environmental and human health hazards, 6-CHLORO-3,5-DIOXO HEXANIC ACID, 1,1-DIMETHYL ETHYL ESTER is subject to strict regulations and guidelines, ensuring its safe handling, storage, and disposal within various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 276249-18-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,6,2,4 and 9 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 276249-18:
(8*2)+(7*7)+(6*6)+(5*2)+(4*4)+(3*9)+(2*1)+(1*8)=164
164 % 10 = 4
So 276249-18-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H15ClO4/c1-10(2,3)15-9(14)5-7(12)4-8(13)6-11/h4-6H2,1-3H3
276249-18-4Relevant academic research and scientific papers
PREPARATION OF 3,5-DIOXO HEXANOATE ESTER IN TWO STEPS
-
Page/Page column 24, (2012/10/18)
The invention discloses a method for the preparation of tert-butyl 6-chloro-3,5- dioxohexanoate from Meldrum's acid derivative and its use for the preparation of tert-butyl (4R,6S)-(6-hydroxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate(BHA), Rosuvastatin and Atorvastatin.
Highly regio- and enantioselective reduction of 3,5-dioxocarboxylates
Wolberg, Michael,Hummel, Werner,Wandrey, Christian,Mueller, Michael
, p. 4306 - 4308 (2007/10/03)
Only the keto group in position C-5 is reduced in the enzymatic reduction of 3,5-dioxocarboxylates by the alcohol dehydrogenase of Lactobacillusbrevis (LBADH; see scheme). The strategy of nature for manipulating β-keto metabolites inspired the development of a chemoenzymatic approach to virtually enantiopure 3,5-dihydroxycarboxylate building blocks. The crucial enzymatic step can be performed on an attractively large scale.